Kenji Nakamoto

428 total citations
24 papers, 178 citations indexed

About

Kenji Nakamoto is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Kenji Nakamoto has authored 24 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ophthalmology, 8 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Kenji Nakamoto's work include Glaucoma and retinal disorders (20 papers), Retinal Diseases and Treatments (5 papers) and Retinal Development and Disorders (4 papers). Kenji Nakamoto is often cited by papers focused on Glaucoma and retinal disorders (20 papers), Retinal Diseases and Treatments (5 papers) and Retinal Development and Disorders (4 papers). Kenji Nakamoto collaborates with scholars based in Japan and France. Kenji Nakamoto's co-authors include Noriko Yasuda, Tsutomu Igarashi, Hiroshi Takahashi, Takashi Okada, Shuhei Kameya, Toru Igarashi, Yukihiko Mashima, Tomoyo Funayama, Yoshihiro Hotta and Koichi Miyaki and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Journal of Glaucoma and Acta Ophthalmologica.

In The Last Decade

Kenji Nakamoto

20 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Nakamoto Japan 8 153 65 65 28 22 24 178
Corrado Gizzi Italy 9 198 1.3× 66 1.0× 106 1.6× 17 0.6× 18 0.8× 20 249
Maurizio Digiuni Italy 9 188 1.2× 40 0.6× 109 1.7× 44 1.6× 16 0.7× 14 229
Shane Havens United States 8 276 1.8× 66 1.0× 137 2.1× 28 1.0× 27 1.2× 21 312
J K H Chua China 6 251 1.6× 112 1.7× 106 1.6× 26 0.9× 29 1.3× 6 296
Neeru A. Vallabh United Kingdom 10 265 1.7× 111 1.7× 221 3.4× 71 2.5× 13 0.6× 25 381
Syril Dorairaj United States 8 271 1.8× 26 0.4× 202 3.1× 18 0.6× 30 1.4× 19 287
Leonardo Mastropasqua Italy 7 113 0.7× 30 0.5× 90 1.4× 77 2.8× 16 0.7× 13 177
Jinghong Sang China 6 164 1.1× 31 0.5× 77 1.2× 7 0.3× 62 2.8× 8 196
Masahide Yanagi Japan 6 220 1.4× 25 0.4× 160 2.5× 29 1.0× 17 0.8× 9 252
Yizhen Tang China 10 195 1.3× 65 1.0× 109 1.7× 21 0.8× 10 0.5× 21 251

Countries citing papers authored by Kenji Nakamoto

Since Specialization
Citations

This map shows the geographic impact of Kenji Nakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Nakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Nakamoto more than expected).

Fields of papers citing papers by Kenji Nakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Nakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Nakamoto. The network helps show where Kenji Nakamoto may publish in the future.

Co-authorship network of co-authors of Kenji Nakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Nakamoto. A scholar is included among the top collaborators of Kenji Nakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Nakamoto. Kenji Nakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goto, Midori, et al.. (2025). A Case Report of Intravitreal Aflibercept for Iris Metastasis from Small Cell Lung Carcinoma with Neovascular Glaucoma. Case Reports in Ophthalmology. 16(1). 215–220.
2.
Nakamoto, Kenji, et al.. (2022). Statistical Analysis of Factors Affecting Surgically Induced Astigmatism Following Trabeculectomy. Clinical ophthalmology. Volume 16. 3833–3839. 2 indexed citations
3.
Igarashi, Tsutomu, Kenji Nakamoto, Hisaharu Suzuki, et al.. (2021). Brain-derived Neurotrophic Factor in the Aqueous Humor of Glaucoma Patients. Journal of Nippon Medical School. 88(2). 128–132. 7 indexed citations
4.
Igarashi, Tsutomu, et al.. (2021). Changes in the Ganglion Cell Complex after Inner Limiting Membrane Peeling for Epiretinal Membrane in Glaucoma Patients. Journal of Nippon Medical School. 88(2). 97–102. 2 indexed citations
5.
Takazawa, Kenji, et al.. (2021). Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Clinical ophthalmology. Volume 15. 3997–4003. 6 indexed citations
6.
Nakamoto, Kenji, Mika Hayashi, Kiyoko Gocho, et al.. (2021). Multimodal imaging analysis of macular dystrophy in patient with maternally inherited diabetes and deafness (MIDD) with m.3243A>G mutation. Ophthalmic Genetics. 42(3). 304–311. 7 indexed citations
7.
Igarashi, Tsutomu, Kenji Nakamoto, Hisaharu Suzuki, et al.. (2020). Serum Brain-Derived Neurotrophic Factor in Glaucoma Patients in Japan: An Observational Study. Journal of Nippon Medical School. 87(6). 339–345. 9 indexed citations
9.
Itoh, Yoshinori, Kenji Nakamoto, Hiroshi Horiguchi, et al.. (2017). Twenty-Four-Hour Variation of Intraocular Pressure in Primary Open-Angle Glaucoma Treated with Triple Eye Drops. Journal of Ophthalmology. 2017. 1–6. 8 indexed citations
10.
Nakamoto, Kenji, et al.. (2017). Clinical statistics for secondary glaucoma in patients with scleritis. Investigative Ophthalmology & Visual Science. 58(8). 552–552.
12.
Igarashi, Tsutomu, Koichi Miyake, Kazuhisa Takahashi, et al.. (2017). New innovations for ocular gene therapy. 13(2). 88–96.
13.
Nakamoto, Kenji & Noriko Yasuda. (2010). Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma. Japanese Journal of Ophthalmology. 54(2). 140–143. 10 indexed citations
14.
Fujita, Kyoko, et al.. (2008). [The relationship between difficulty in daily living and binocular visual field in patients with glaucoma].. PubMed. 112(5). 447–50. 5 indexed citations
15.
Nakamoto, Kenji, et al.. (2008). [Correlation of age and intraocular pressure with visual field damage in patients with normal-tension glaucoma].. PubMed. 112(4). 371–5. 3 indexed citations
16.
Nakamoto, Kenji & Noriko Yasuda. (2007). Effect of Concomitant Use of Latanoprost and Brinzolamide on 24-hour Variation of IOP in Normal-tension Glaucoma. Journal of Glaucoma. 16(4). 352–357. 28 indexed citations
17.
Yasuda, Noriko, Kenji Nakamoto, Tomoyo Funayama, & Yukihiko Mashima. (2006). [Low penetrance of His26Asp mutation in the optineurin gene in a Japanese family with normal-tension glaucoma].. PubMed. 110(8). 594–600. 1 indexed citations
18.
Ishikawa, K., Tomoyo Funayama, Yuichiro Ohtake, et al.. (2005). Association between glaucoma and gene polymorphism of endothelin type A receptor.. PubMed. 11. 431–7. 37 indexed citations
19.
Nakamoto, Kenji, et al.. (2004). Effect of Latanoprost on Diurnal Variations of Intraocular Pressure in Normal-tension Glaucoma. Japanese Journal of Ophthalmology. 48(2). 184–184. 2 indexed citations
20.
Nakamoto, Kenji, et al.. (2004). [Comparison of the effects of latanoprost and timolol gel-forming solution on diurnal variation of intraocular pressure in normal-tension glaucoma].. PubMed. 108(7). 401–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026